Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

afamitresgene autoleucel

View Patient Information
A preparation of autologous human T lymphocytes transduced with a lentiviral vector encoding an affinity-enhanced T-cell receptor (TCR) specific for the human leukocyte antigen (HLA)-A2-restricted peptide human melanoma antigen A4 (MAGE-A4) C1032, with potential immunostimulatory and antineoplastic activities. Upon leukapheresis, isolation, transduction, expansion ex vivo, and reintroduction into the patient, afamitresgene autoleucel targets and binds to tumor cells expressing MAGE-A4. This results in cell death of MAGE-A4-expressing tumor cells. The tumor-associated antigen (TAA) MAGE-A4, a member of the MAGE-A family of cancer testis antigens, is overexpressed by a variety of cancer cell types.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:afami-cel
autologous genetically-modified MAGE-A4 C1032 T cells
autologous genetically-modified MAGE-A4 C1032 T lymphocytes
MAGE-A4 SPEAR T cells
MAGE-A4C1032T
SPEAR T-cell ADP-A2M4
US brand name:Tecelra
Code name:ADP-A2M4
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search